US FDA Commissioner Scott Gottlieb has two additional centers of excellence already in mind – immunology and neuroscience – should the model implemented for oncology work as planned.
Both, like the Oncology Center of Excellence that launched at the beginning of 2017, would allow experts in the fields from across the various product centers and offices at FDA to